Skip to content

Accelerometry at the Neck: Comparison With m. Adductor Pollicis Stimulation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01849198
Enrollment
60
Registered
2013-05-08
Start date
2013-04-30
Completion date
2015-12-31
Last updated
2016-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Feasibility of Measurement of a Neuromuscular Block at the m. Trapezius

Keywords

accelerometry, neuromuscular block, m. trapezius

Brief summary

Accelerometric Assessment of neuromuscular block during anaesthesia is routinely performed at the M. adductor pollicis. However, many operations require positioning of the patients with arms attached to the body. In these situations, the anaesthesiologist has no access to the m.adductor pollicis. In this study, a new position of accelerometry at the neck is evaluated: Stimulation of the n. accessorius with accelerometry of the m. trapezius.

Interventions

DEVICEaccelerometry m. trapezius and m. adductor pollicis

Sponsors

Kreiskrankenhaus Dormagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing general anaesthesia with endotracheal intubation * weight 50-90 kg

Exclusion criteria

* Pregnancy * allergy to one of the drugs used * risk of pulmonary aspiration * expected difficulties with endotracheal intubation * intake of drugs known to influence neuromuscular block * infection (CRP \> 0,5 mg/dl, leukocyte count \> 12000/µl)

Design outcomes

Primary

MeasureTime frameDescription
Recovery to a train of four ratio of 0.960 minutesComparison between time to recovery \[s\] to a train of four ratio of 0.9 between both groups

Secondary

MeasureTime frameDescription
onset of neuromuscular block10 minComparison of onset time \[s\] between both groups. Onset time is defined as decrease of T1 to \< 5% of initial twitch height.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026